

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Golgi transport vesicle coating (GO:0048200) | 7.10552236 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 7.10552236 |
| 3 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 5.61125929 |
| 4 | protein retention in ER lumen (GO:0006621) | 5.19575546 |
| 5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.07146332 |
| 6 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.07146332 |
| 7 | mitotic chromosome condensation (GO:0007076) | 4.99609397 |
| 8 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 4.80342806 |
| 9 | positive regulation of nuclease activity (GO:0032075) | 4.63339783 |
| 10 | nuclear pore complex assembly (GO:0051292) | 4.59527811 |
| 11 | COPII vesicle coating (GO:0048208) | 4.41527622 |
| 12 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.36773182 |
| 13 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.32361190 |
| 14 | endoplasmic reticulum unfolded protein response (GO:0030968) | 4.30794204 |
| 15 | DNA unwinding involved in DNA replication (GO:0006268) | 4.17864205 |
| 16 | regulation of nuclease activity (GO:0032069) | 4.17168986 |
| 17 | cellular protein complex localization (GO:0034629) | 4.17141930 |
| 18 | cellular response to unfolded protein (GO:0034620) | 4.13589921 |
| 19 | 4-hydroxyproline metabolic process (GO:0019471) | 4.11534521 |
| 20 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 4.01961134 |
| 21 | ER-nucleus signaling pathway (GO:0006984) | 3.99673263 |
| 22 | cysteine metabolic process (GO:0006534) | 3.99294205 |
| 23 | regulation of translational fidelity (GO:0006450) | 3.99018441 |
| 24 | exocrine pancreas development (GO:0031017) | 3.92361282 |
| 25 | cellular response to topologically incorrect protein (GO:0035967) | 3.90615838 |
| 26 | nuclear pore organization (GO:0006999) | 3.84198487 |
| 27 | intestinal cholesterol absorption (GO:0030299) | 3.83544741 |
| 28 | valine metabolic process (GO:0006573) | 3.82685822 |
| 29 | protein complex localization (GO:0031503) | 3.77579163 |
| 30 | protein maturation by protein folding (GO:0022417) | 3.76872631 |
| 31 | signal peptide processing (GO:0006465) | 3.73840735 |
| 32 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.67356156 |
| 33 | L-phenylalanine catabolic process (GO:0006559) | 3.67356156 |
| 34 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.61051465 |
| 35 | L-phenylalanine metabolic process (GO:0006558) | 3.61051465 |
| 36 | response to endoplasmic reticulum stress (GO:0034976) | 3.56471138 |
| 37 | sulfur amino acid catabolic process (GO:0000098) | 3.56271515 |
| 38 | activation of Rac GTPase activity (GO:0032863) | 3.55933372 |
| 39 | gonadal mesoderm development (GO:0007506) | 3.51924044 |
| 40 | folic acid metabolic process (GO:0046655) | 3.49975133 |
| 41 | alpha-linolenic acid metabolic process (GO:0036109) | 3.45800752 |
| 42 | pore complex assembly (GO:0046931) | 3.42709923 |
| 43 | vesicle coating (GO:0006901) | 3.40894927 |
| 44 | formation of translation preinitiation complex (GO:0001731) | 3.40888707 |
| 45 | lysine catabolic process (GO:0006554) | 3.40760537 |
| 46 | lysine metabolic process (GO:0006553) | 3.40760537 |
| 47 | apoptotic cell clearance (GO:0043277) | 3.39879434 |
| 48 | peptidyl-asparagine modification (GO:0018196) | 3.29138126 |
| 49 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.28914500 |
| 50 | cellular modified amino acid catabolic process (GO:0042219) | 3.26843601 |
| 51 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.25831240 |
| 52 | DNA replication initiation (GO:0006270) | 3.23711352 |
| 53 | mitotic sister chromatid segregation (GO:0000070) | 3.22481411 |
| 54 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.21698397 |
| 55 | protein carboxylation (GO:0018214) | 3.21698397 |
| 56 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.18010092 |
| 57 | response to unfolded protein (GO:0006986) | 3.17969538 |
| 58 | pentose-phosphate shunt (GO:0006098) | 3.16238243 |
| 59 | regulation of translational termination (GO:0006449) | 3.15823462 |
| 60 | complement activation, classical pathway (GO:0006958) | 3.15291355 |
| 61 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.15190622 |
| 62 | apoptotic process involved in morphogenesis (GO:0060561) | 3.14998566 |
| 63 | DNA strand elongation (GO:0022616) | 3.13137266 |
| 64 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.12883503 |
| 65 | desmosome organization (GO:0002934) | 3.11094587 |
| 66 | focal adhesion assembly (GO:0048041) | 3.10756509 |
| 67 | cell-substrate adherens junction assembly (GO:0007045) | 3.10756509 |
| 68 | sequestering of metal ion (GO:0051238) | 3.10260376 |
| 69 | ribosomal small subunit biogenesis (GO:0042274) | 3.09904414 |
| 70 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.09559076 |
| 71 | transcytosis (GO:0045056) | 3.07660476 |
| 72 | response to topologically incorrect protein (GO:0035966) | 3.06848585 |
| 73 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 3.06722304 |
| 74 | protein localization to endosome (GO:0036010) | 3.04914341 |
| 75 | adherens junction assembly (GO:0034333) | 3.03528234 |
| 76 | protein N-linked glycosylation (GO:0006487) | 3.02276046 |
| 77 | regulation of early endosome to late endosome transport (GO:2000641) | 3.01153341 |
| 78 | mitotic sister chromatid cohesion (GO:0007064) | 2.95981656 |
| 79 | tricarboxylic acid metabolic process (GO:0072350) | 2.91665570 |
| 80 | regulation of cholesterol homeostasis (GO:2000188) | 2.90660963 |
| 81 | homocysteine metabolic process (GO:0050667) | 2.89218741 |
| 82 | nitrogen cycle metabolic process (GO:0071941) | 2.88966607 |
| 83 | sister chromatid segregation (GO:0000819) | 2.86819286 |
| 84 | low-density lipoprotein particle clearance (GO:0034383) | 2.86663676 |
| 85 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.86336825 |
| 86 | NADPH regeneration (GO:0006740) | 2.85445117 |
| 87 | complement activation, alternative pathway (GO:0006957) | 2.85198993 |
| 88 | aromatic amino acid family catabolic process (GO:0009074) | 2.85042931 |
| 89 | negative regulation of fibrinolysis (GO:0051918) | 2.84766701 |
| 90 | complement activation (GO:0006956) | 2.83425130 |
| 91 | chromosome condensation (GO:0030261) | 2.82906438 |
| 92 | cell-substrate junction assembly (GO:0007044) | 2.82763739 |
| 93 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.82741047 |
| 94 | protein localization to chromosome, centromeric region (GO:0071459) | 2.81848653 |
| 95 | regulation of protein activation cascade (GO:2000257) | 2.80734859 |
| 96 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.80504895 |
| 97 | intestinal absorption (GO:0050892) | 2.79554261 |
| 98 | oxaloacetate metabolic process (GO:0006107) | 2.79101127 |
| 99 | epithelial cell-cell adhesion (GO:0090136) | 2.77515461 |
| 100 | GDP-mannose metabolic process (GO:0019673) | 2.74682967 |
| 101 | mitotic nuclear envelope disassembly (GO:0007077) | 2.74164108 |
| 102 | regulation of complement activation (GO:0030449) | 2.73918091 |
| 103 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 2.73653260 |
| 104 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.73348286 |
| 105 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.73006268 |
| 106 | 2-oxoglutarate metabolic process (GO:0006103) | 2.72303562 |
| 107 | hemidesmosome assembly (GO:0031581) | 2.71504236 |
| 108 | basement membrane organization (GO:0071711) | 2.71419447 |
| 109 | maternal placenta development (GO:0001893) | 2.71019102 |
| 110 | RNA stabilization (GO:0043489) | 2.68285947 |
| 111 | mRNA stabilization (GO:0048255) | 2.68285947 |
| 112 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.67160561 |
| 113 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.67110761 |
| 114 | protein export from nucleus (GO:0006611) | 2.66392134 |
| 115 | regulation of RNA export from nucleus (GO:0046831) | 2.66099367 |
| 116 | protein autoprocessing (GO:0016540) | 2.66008184 |
| 117 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.65834139 |
| 118 | peptidyl-proline hydroxylation (GO:0019511) | 2.64969328 |
| 119 | drug transmembrane transport (GO:0006855) | 2.64434893 |
| 120 | DNA duplex unwinding (GO:0032508) | 2.63648214 |
| 121 | membrane disassembly (GO:0030397) | 2.62217900 |
| 122 | nuclear envelope disassembly (GO:0051081) | 2.62217900 |
| 123 | proline biosynthetic process (GO:0006561) | 2.61598923 |
| 124 | embryonic process involved in female pregnancy (GO:0060136) | 2.59858271 |
| 125 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.59655682 |
| 126 | mannose metabolic process (GO:0006013) | 2.59086966 |
| 127 | proline metabolic process (GO:0006560) | 2.58934594 |
| 128 | glyoxylate metabolic process (GO:0046487) | 2.57559536 |
| 129 | regulation of histone H3-K27 methylation (GO:0061085) | 2.57270427 |
| 130 | mitochondrial DNA metabolic process (GO:0032042) | 2.53090909 |
| 131 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.53004032 |
| 132 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.52889307 |
| 133 | kynurenine metabolic process (GO:0070189) | 2.52882643 |
| 134 | high-density lipoprotein particle remodeling (GO:0034375) | 2.52845833 |
| 135 | urea metabolic process (GO:0019627) | 2.52161440 |
| 136 | urea cycle (GO:0000050) | 2.52161440 |
| 137 | nuclear envelope organization (GO:0006998) | 2.50569906 |
| 138 | reverse cholesterol transport (GO:0043691) | 2.49347394 |
| 139 | plasma lipoprotein particle clearance (GO:0034381) | 2.49013543 |
| 140 | cell redox homeostasis (GO:0045454) | 2.48803904 |
| 141 | glucose catabolic process (GO:0006007) | 2.48195523 |
| 142 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.47927872 |
| 143 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.47795982 |
| 144 | ribosome biogenesis (GO:0042254) | 2.47013400 |
| 145 | pinocytosis (GO:0006907) | 2.46857154 |
| 146 | bile acid biosynthetic process (GO:0006699) | 2.46731795 |
| 147 | mitotic nuclear envelope reassembly (GO:0007084) | 2.46554609 |
| 148 | nuclear envelope reassembly (GO:0031468) | 2.46554609 |
| 149 | tyrosine metabolic process (GO:0006570) | 2.45484599 |
| 150 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.45289387 |
| 151 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.45172481 |
| 152 | negative regulation of cell size (GO:0045792) | 2.45074970 |
| 153 | regulation of mitotic spindle organization (GO:0060236) | 2.44730789 |
| 154 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.44456837 |
| 155 | hormone catabolic process (GO:0042447) | 2.43343127 |
| 156 | acute-phase response (GO:0006953) | 2.43077116 |
| 157 | negative regulation of cholesterol transport (GO:0032375) | 2.43075221 |
| 158 | negative regulation of sterol transport (GO:0032372) | 2.43075221 |
| 159 | establishment of apical/basal cell polarity (GO:0035089) | 2.42913455 |
| 160 | zinc ion transport (GO:0006829) | 2.42849016 |
| 161 | protein activation cascade (GO:0072376) | 2.41055814 |
| 162 | DNA geometric change (GO:0032392) | 2.40497107 |
| 163 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.40239579 |
| 164 | regulation of fibrinolysis (GO:0051917) | 2.40111721 |
| 165 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.40111449 |
| 166 | midgut development (GO:0007494) | 2.39531970 |
| 167 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.38925459 |
| 168 | tRNA methylation (GO:0030488) | 2.38913526 |
| 169 | response to laminar fluid shear stress (GO:0034616) | 2.38868497 |
| 170 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.38690928 |
| 171 | atrioventricular valve morphogenesis (GO:0003181) | 2.38395457 |
| 172 | DNA packaging (GO:0006323) | 2.37865923 |
| 173 | Golgi organization (GO:0007030) | 2.37650596 |
| 174 | macroautophagy (GO:0016236) | 2.36785240 |
| 175 | ethanol oxidation (GO:0006069) | 2.36215522 |
| 176 | heterochromatin organization (GO:0070828) | 2.35436775 |
| 177 | regulation of plasminogen activation (GO:0010755) | 2.35334628 |
| 178 | skin morphogenesis (GO:0043589) | 2.34755646 |
| 179 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.34288759 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.75559061 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.53316019 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.96972740 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.67366158 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.59749963 |
| 6 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.08463760 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.01277170 |
| 8 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.75987767 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.74658926 |
| 10 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.49592940 |
| 11 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.44842626 |
| 12 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.41743704 |
| 13 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.32245682 |
| 14 | * MYC_22102868_ChIP-Seq_BL_Human | 2.24382461 |
| 15 | GATA1_22025678_ChIP-Seq_K562_Human | 2.23674388 |
| 16 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.21834436 |
| 17 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.17076314 |
| 18 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.12860748 |
| 19 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.04967347 |
| 20 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.02560441 |
| 21 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 2.01605908 |
| 22 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.99704211 |
| 23 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.97846861 |
| 24 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.93639158 |
| 25 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.84901107 |
| 26 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.82145352 |
| 27 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.81332667 |
| 28 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.76922554 |
| 29 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.76895715 |
| 30 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.75082913 |
| 31 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.74273766 |
| 32 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.72252916 |
| 33 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.71811460 |
| 34 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.68308566 |
| 35 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.65567148 |
| 36 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.65565993 |
| 37 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.64957879 |
| 38 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.64525507 |
| 39 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.62985537 |
| 40 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.62955897 |
| 41 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.62476686 |
| 42 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.59539922 |
| 43 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.56139771 |
| 44 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.55198008 |
| 45 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.52746638 |
| 46 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.52516722 |
| 47 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.52404367 |
| 48 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.52076754 |
| 49 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51611823 |
| 50 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.51177793 |
| 51 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.49348923 |
| 52 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.47455609 |
| 53 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.46288163 |
| 54 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.45868568 |
| 55 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.45356024 |
| 56 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.44662802 |
| 57 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.43709372 |
| 58 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.41882526 |
| 59 | MAF_26560356_Chip-Seq_TH1_Human | 1.40829122 |
| 60 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.39882140 |
| 61 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.39614617 |
| 62 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.37941444 |
| 63 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.37936704 |
| 64 | UTX_26944678_Chip-Seq_JUKART_Human | 1.36624879 |
| 65 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.35449469 |
| 66 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.35148637 |
| 67 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.34514111 |
| 68 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.32908769 |
| 69 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.32429693 |
| 70 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.31339911 |
| 71 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.31275425 |
| 72 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.31206920 |
| 73 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.30715031 |
| 74 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.30700631 |
| 75 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.29160148 |
| 76 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.28893029 |
| 77 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.27511997 |
| 78 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.26563371 |
| 79 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.25159162 |
| 80 | MYB_26560356_Chip-Seq_TH2_Human | 1.24350636 |
| 81 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.24316343 |
| 82 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22865695 |
| 83 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.22206833 |
| 84 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.21984622 |
| 85 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.20610403 |
| 86 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.20005207 |
| 87 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.19824227 |
| 88 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.19312658 |
| 89 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.18999434 |
| 90 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.18857378 |
| 91 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.18591461 |
| 92 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.17806183 |
| 93 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.17679973 |
| 94 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.16432290 |
| 95 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.15311133 |
| 96 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.14918038 |
| 97 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.14423450 |
| 98 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.14012042 |
| 99 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.12462642 |
| 100 | MYB_26560356_Chip-Seq_TH1_Human | 1.11923184 |
| 101 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.11162499 |
| 102 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.10948687 |
| 103 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.10774946 |
| 104 | * P68_20966046_ChIP-Seq_HELA_Human | 1.09686478 |
| 105 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.09192599 |
| 106 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.09184793 |
| 107 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.08804817 |
| 108 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08468639 |
| 109 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.08412254 |
| 110 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.06432445 |
| 111 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.05757837 |
| 112 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.05379150 |
| 113 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.04828164 |
| 114 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.04298513 |
| 115 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.04022699 |
| 116 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.03521454 |
| 117 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03457062 |
| 118 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.03310985 |
| 119 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.03130778 |
| 120 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.03013675 |
| 121 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.02588488 |
| 122 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.01731186 |
| 123 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.00963933 |
| 124 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.00453889 |
| 125 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.99326241 |
| 126 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.98804256 |
| 127 | GATA1_19941826_ChIP-Seq_K562_Human | 0.98399776 |
| 128 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.95871179 |
| 129 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95601340 |
| 130 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.95505825 |
| 131 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.95505825 |
| 132 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.94898047 |
| 133 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.94513345 |
| 134 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.94178305 |
| 135 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.94109863 |
| 136 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.94105669 |
| 137 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.93273427 |
| 138 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93119970 |
| 139 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.92997298 |
| 140 | MAF_26560356_Chip-Seq_TH2_Human | 0.92751366 |
| 141 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.92256081 |
| 142 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.92062581 |
| 143 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.91235600 |
| 144 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.90627475 |
| 145 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.90319166 |
| 146 | SPI1_23127762_ChIP-Seq_K562_Human | 0.89943921 |
| 147 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.89459115 |
| 148 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.89078540 |
| 149 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.89029305 |
| 150 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.87450149 |
| 151 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.87310120 |
| 152 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.87096810 |
| 153 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.86977650 |
| 154 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.86775042 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.58808290 |
| 2 | MP0005365_abnormal_bile_salt | 3.58695801 |
| 3 | MP0005360_urolithiasis | 3.25223931 |
| 4 | MP0001666_abnormal_nutrient_absorption | 3.05010412 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 2.98590958 |
| 6 | MP0010234_abnormal_vibrissa_follicle | 2.98145865 |
| 7 | MP0003300_gastrointestinal_ulcer | 2.94979196 |
| 8 | MP0005076_abnormal_cell_differentiation | 2.89411979 |
| 9 | MP0005083_abnormal_biliary_tract | 2.72067547 |
| 10 | MP0005451_abnormal_body_composition | 2.65164973 |
| 11 | MP0004233_abnormal_muscle_weight | 2.59161462 |
| 12 | MP0003705_abnormal_hypodermis_morpholog | 2.58353317 |
| 13 | MP0003111_abnormal_nucleus_morphology | 2.48166639 |
| 14 | MP0003693_abnormal_embryo_hatching | 2.46069020 |
| 15 | MP0005058_abnormal_lysosome_morphology | 2.44190518 |
| 16 | MP0005220_abnormal_exocrine_pancreas | 2.35625625 |
| 17 | MP0009840_abnormal_foam_cell | 2.33980480 |
| 18 | MP0003195_calcinosis | 2.26407305 |
| 19 | MP0002877_abnormal_melanocyte_morpholog | 2.22732473 |
| 20 | MP0004957_abnormal_blastocyst_morpholog | 2.20147030 |
| 21 | MP0003252_abnormal_bile_duct | 2.14048589 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 2.07579887 |
| 23 | MP0002796_impaired_skin_barrier | 2.04897807 |
| 24 | MP0010329_abnormal_lipoprotein_level | 2.03635630 |
| 25 | MP0010094_abnormal_chromosome_stability | 1.99051743 |
| 26 | MP0008438_abnormal_cutaneous_collagen | 1.98024387 |
| 27 | MP0003303_peritoneal_inflammation | 1.96551400 |
| 28 | MP0003077_abnormal_cell_cycle | 1.93819189 |
| 29 | MP0001849_ear_inflammation | 1.93391318 |
| 30 | MP0003868_abnormal_feces_composition | 1.92351396 |
| 31 | MP0002909_abnormal_adrenal_gland | 1.86055288 |
| 32 | MP0008875_abnormal_xenobiotic_pharmacok | 1.84353187 |
| 33 | MP0006054_spinal_hemorrhage | 1.83521398 |
| 34 | MP0005501_abnormal_skin_physiology | 1.82918204 |
| 35 | MP0003453_abnormal_keratinocyte_physiol | 1.82710789 |
| 36 | MP0000537_abnormal_urethra_morphology | 1.76531358 |
| 37 | MP0009643_abnormal_urine_homeostasis | 1.72348300 |
| 38 | MP0002693_abnormal_pancreas_physiology | 1.71768840 |
| 39 | MP0000609_abnormal_liver_physiology | 1.71670839 |
| 40 | MP0010307_abnormal_tumor_latency | 1.68890123 |
| 41 | MP0003436_decreased_susceptibility_to | 1.68730631 |
| 42 | MP0008260_abnormal_autophagy | 1.67738111 |
| 43 | MP0001730_embryonic_growth_arrest | 1.66220501 |
| 44 | MP0005623_abnormal_meninges_morphology | 1.64920118 |
| 45 | MP0001348_abnormal_lacrimal_gland | 1.63536391 |
| 46 | MP0002396_abnormal_hematopoietic_system | 1.60750567 |
| 47 | MP0001944_abnormal_pancreas_morphology | 1.58933569 |
| 48 | MP0004858_abnormal_nervous_system | 1.57848615 |
| 49 | MP0002060_abnormal_skin_morphology | 1.56554047 |
| 50 | MP0005332_abnormal_amino_acid | 1.56510332 |
| 51 | MP0008932_abnormal_embryonic_tissue | 1.53405437 |
| 52 | MP0000350_abnormal_cell_proliferation | 1.53368641 |
| 53 | MP0004808_abnormal_hematopoietic_stem | 1.50848562 |
| 54 | MP0002138_abnormal_hepatobiliary_system | 1.44967529 |
| 55 | MP0001661_extended_life_span | 1.44572614 |
| 56 | MP0002118_abnormal_lipid_homeostasis | 1.42483986 |
| 57 | MP0000604_amyloidosis | 1.39410108 |
| 58 | MP0005319_abnormal_enzyme/_coenzyme | 1.39124730 |
| 59 | MP0005257_abnormal_intraocular_pressure | 1.38321906 |
| 60 | MP0002166_altered_tumor_susceptibility | 1.38112130 |
| 61 | MP0003091_abnormal_cell_migration | 1.36960768 |
| 62 | MP0003172_abnormal_lysosome_physiology | 1.35654147 |
| 63 | MP0001835_abnormal_antigen_presentation | 1.32340552 |
| 64 | MP0000678_abnormal_parathyroid_gland | 1.29806967 |
| 65 | MP0004264_abnormal_extraembryonic_tissu | 1.28789811 |
| 66 | MP0003566_abnormal_cell_adhesion | 1.28732552 |
| 67 | MP0008057_abnormal_DNA_replication | 1.28017556 |
| 68 | MP0000733_abnormal_muscle_development | 1.27500439 |
| 69 | MP0005464_abnormal_platelet_physiology | 1.26956743 |
| 70 | MP0004947_skin_inflammation | 1.26161793 |
| 71 | MP0002080_prenatal_lethality | 1.25728897 |
| 72 | MP0001765_abnormal_ion_homeostasis | 1.25686180 |
| 73 | MP0005636_abnormal_mineral_homeostasis | 1.25240245 |
| 74 | MP0010352_gastrointestinal_tract_polyps | 1.22119363 |
| 75 | MP0004782_abnormal_surfactant_physiolog | 1.20825675 |
| 76 | MP0000685_abnormal_immune_system | 1.20179711 |
| 77 | MP0008961_abnormal_basal_metabolism | 1.20092344 |
| 78 | MP0005409_darkened_coat_color | 1.19812762 |
| 79 | MP0000013_abnormal_adipose_tissue | 1.19782698 |
| 80 | MP0001845_abnormal_inflammatory_respons | 1.19664782 |
| 81 | MP0000579_abnormal_nail_morphology | 1.19376705 |
| 82 | MP0002086_abnormal_extraembryonic_tissu | 1.18920634 |
| 83 | MP0002078_abnormal_glucose_homeostasis | 1.17897236 |
| 84 | MP0001216_abnormal_epidermal_layer | 1.17175603 |
| 85 | MP0003984_embryonic_growth_retardation | 1.17111872 |
| 86 | MP0005380_embryogenesis_phenotype | 1.17108826 |
| 87 | MP0001672_abnormal_embryogenesis/_devel | 1.17108826 |
| 88 | MP0003806_abnormal_nucleotide_metabolis | 1.17007741 |
| 89 | MP0009333_abnormal_splenocyte_physiolog | 1.16828171 |
| 90 | MP0001756_abnormal_urination | 1.15963976 |
| 91 | MP0008007_abnormal_cellular_replicative | 1.15600407 |
| 92 | MP0005621_abnormal_cell_physiology | 1.15559797 |
| 93 | MP0002089_abnormal_postnatal_growth/wei | 1.15445320 |
| 94 | MP0004272_abnormal_basement_membrane | 1.14172216 |
| 95 | MP0008469_abnormal_protein_level | 1.13582882 |
| 96 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.12785076 |
| 97 | MP0010155_abnormal_intestine_physiology | 1.12024909 |
| 98 | MP0009053_abnormal_anal_canal | 1.11168446 |
| 99 | MP0009780_abnormal_chondrocyte_physiolo | 1.09829003 |
| 100 | MP0002088_abnormal_embryonic_growth/wei | 1.09772965 |
| 101 | MP0004043_abnormal_pH_regulation | 1.07865569 |
| 102 | MP0010030_abnormal_orbit_morphology | 1.05800841 |
| 103 | MP0000598_abnormal_liver_morphology | 1.05444278 |
| 104 | MP0001533_abnormal_skeleton_physiology | 1.05063349 |
| 105 | MP0003866_abnormal_defecation | 1.04374630 |
| 106 | MP0001881_abnormal_mammary_gland | 1.03496821 |
| 107 | MP0004185_abnormal_adipocyte_glucose | 1.03306966 |
| 108 | MP0003183_abnormal_peptide_metabolism | 1.02025046 |
| 109 | MP0003763_abnormal_thymus_physiology | 1.01518907 |
| 110 | MP0002098_abnormal_vibrissa_morphology | 1.00996655 |
| 111 | MP0001873_stomach_inflammation | 1.00571778 |
| 112 | MP0005310_abnormal_salivary_gland | 0.99925003 |
| 113 | MP0005275_abnormal_skin_tensile | 0.99176579 |
| 114 | MP0001697_abnormal_embryo_size | 0.98866397 |
| 115 | MP0003656_abnormal_erythrocyte_physiolo | 0.98633984 |
| 116 | MP0003329_amyloid_beta_deposits | 0.97609020 |
| 117 | MP0001790_abnormal_immune_system | 0.96663800 |
| 118 | MP0005387_immune_system_phenotype | 0.96663800 |
| 119 | MP0003959_abnormal_lean_body | 0.96339348 |
| 120 | MP0005000_abnormal_immune_tolerance | 0.94041373 |
| 121 | MP0005025_abnormal_response_to | 0.94019262 |
| 122 | MP0000313_abnormal_cell_death | 0.93490414 |
| 123 | MP0000627_abnormal_mammary_gland | 0.92908510 |
| 124 | MP0000003_abnormal_adipose_tissue | 0.91428383 |
| 125 | MP0002419_abnormal_innate_immunity | 0.89289106 |
| 126 | MP0009672_abnormal_birth_weight | 0.88829232 |
| 127 | MP0002136_abnormal_kidney_physiology | 0.88712622 |
| 128 | MP0004130_abnormal_muscle_cell | 0.88349218 |
| 129 | MP0003786_premature_aging | 0.87454391 |
| 130 | MP0005384_cellular_phenotype | 0.87432472 |
| 131 | MP0003075_altered_response_to | 0.87399878 |
| 132 | MP0009642_abnormal_blood_homeostasis | 0.86658569 |
| 133 | MP0001800_abnormal_humoral_immune | 0.86208270 |
| 134 | MP0009931_abnormal_skin_appearance | 0.85544544 |
| 135 | MP0000762_abnormal_tongue_morphology | 0.84969631 |
| 136 | MP0005375_adipose_tissue_phenotype | 0.83426289 |
| 137 | MP0001915_intracranial_hemorrhage | 0.83313721 |
| 138 | MP0009785_altered_susceptibility_to | 0.81207178 |
| 139 | MP0008058_abnormal_DNA_repair | 0.81022445 |
| 140 | MP0002896_abnormal_bone_mineralization | 0.80615559 |
| 141 | MP0005666_abnormal_adipose_tissue | 0.80209294 |
| 142 | MP0002019_abnormal_tumor_incidence | 0.79081301 |
| 143 | MP0000858_altered_metastatic_potential | 0.78908087 |
| 144 | MP0002009_preneoplasia | 0.78202732 |
| 145 | MP0002254_reproductive_system_inflammat | 0.78135679 |
| 146 | MP0000566_synostosis | 0.78050778 |
| 147 | MP0000465_gastrointestinal_hemorrhage | 0.77854455 |
| 148 | MP0003186_abnormal_redox_activity | 0.77502507 |
| 149 | MP0002085_abnormal_embryonic_tissue | 0.77282811 |
| 150 | MP0005023_abnormal_wound_healing | 0.77167754 |
| 151 | MP0000467_abnormal_esophagus_morphology | 0.76743864 |
| 152 | MP0001958_emphysema | 0.76577335 |
| 153 | MP0000358_abnormal_cell_content/ | 0.76480210 |
| 154 | MP0010771_integument_phenotype | 0.76319536 |
| 155 | MP0004019_abnormal_vitamin_homeostasis | 0.76099058 |
| 156 | MP0002723_abnormal_immune_serum | 0.75437133 |
| 157 | MP0002452_abnormal_antigen_presenting | 0.75219322 |
| 158 | MP0002084_abnormal_developmental_patter | 0.74625511 |
| 159 | MP0010678_abnormal_skin_adnexa | 0.74355374 |
| 160 | MP0001243_abnormal_dermal_layer | 0.74164054 |
| 161 | MP0003638_abnormal_response/metabolism_ | 0.74154196 |
| 162 | MP0002970_abnormal_white_adipose | 0.73368183 |
| 163 | MP0000377_abnormal_hair_follicle | 0.72293248 |
| 164 | MP0005535_abnormal_body_temperature | 0.72081355 |
| 165 | MP0000490_abnormal_crypts_of | 0.71557124 |
| 166 | MP0003795_abnormal_bone_structure | 0.71526888 |
| 167 | MP0009763_increased_sensitivity_to | 0.69875773 |
| 168 | MP0002933_joint_inflammation | 0.69868948 |
| 169 | MP0002006_tumorigenesis | 0.69520240 |
| 170 | MP0005448_abnormal_energy_balance | 0.69257068 |
| 171 | MP0000477_abnormal_intestine_morphology | 0.69211795 |
| 172 | MP0005671_abnormal_response_to | 0.68964303 |
| 173 | MP0010630_abnormal_cardiac_muscle | 0.68132950 |
| 174 | MP0000747_muscle_weakness | 0.65440913 |
| 175 | MP0005197_abnormal_uvea_morphology | 0.63032707 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the intrinsic pathway (HP:0010989) | 3.98189001 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.60146291 |
| 3 | Deep venous thrombosis (HP:0002625) | 3.58792169 |
| 4 | Abnormality of the common coagulation pathway (HP:0010990) | 3.47583447 |
| 5 | Premature rupture of membranes (HP:0001788) | 3.37085585 |
| 6 | Dysostosis multiplex (HP:0000943) | 3.34642983 |
| 7 | Mucopolysacchariduria (HP:0008155) | 3.24892567 |
| 8 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.24892567 |
| 9 | Vertebral compression fractures (HP:0002953) | 3.22018563 |
| 10 | Sparse lateral eyebrow (HP:0005338) | 3.21896759 |
| 11 | Vacuolated lymphocytes (HP:0001922) | 3.19927992 |
| 12 | Xanthomatosis (HP:0000991) | 3.17967002 |
| 13 | Hyperacusis (HP:0010780) | 3.10330335 |
| 14 | Hypoglycemic coma (HP:0001325) | 3.09402538 |
| 15 | Ankyloglossia (HP:0010296) | 3.08302514 |
| 16 | Ulnar bowing (HP:0003031) | 3.04058862 |
| 17 | Ketosis (HP:0001946) | 3.03134494 |
| 18 | Abnormality of the distal phalanges of the toes (HP:0010182) | 3.01661678 |
| 19 | Ketoacidosis (HP:0001993) | 2.89877849 |
| 20 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.87549359 |
| 21 | Complement deficiency (HP:0004431) | 2.84247140 |
| 22 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.83364799 |
| 23 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.83364799 |
| 24 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.83364799 |
| 25 | Trismus (HP:0000211) | 2.83261984 |
| 26 | Broad face (HP:0000283) | 2.83137637 |
| 27 | Abnormality of oral frenula (HP:0000190) | 2.75844597 |
| 28 | Short nail (HP:0001799) | 2.70975489 |
| 29 | Gout (HP:0001997) | 2.67930646 |
| 30 | Intrahepatic cholestasis (HP:0001406) | 2.64621228 |
| 31 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.62705926 |
| 32 | Osteolytic defects of the hand bones (HP:0009699) | 2.62705926 |
| 33 | Flat acetabular roof (HP:0003180) | 2.57174699 |
| 34 | Increased cerebral lipofuscin (HP:0011813) | 2.54583336 |
| 35 | Distal lower limb amyotrophy (HP:0008944) | 2.53970909 |
| 36 | Selective tooth agenesis (HP:0001592) | 2.53488111 |
| 37 | Asymmetry of the thorax (HP:0001555) | 2.51247178 |
| 38 | Late onset (HP:0003584) | 2.45233230 |
| 39 | Myocardial infarction (HP:0001658) | 2.45093187 |
| 40 | Prolonged partial thromboplastin time (HP:0003645) | 2.42250694 |
| 41 | Fat malabsorption (HP:0002630) | 2.37801251 |
| 42 | Long palpebral fissure (HP:0000637) | 2.37494947 |
| 43 | Elbow flexion contracture (HP:0002987) | 2.35660673 |
| 44 | Deviation of the thumb (HP:0009603) | 2.32372396 |
| 45 | Abnormality of the Achilles tendon (HP:0005109) | 2.30779168 |
| 46 | Hypoglycemic seizures (HP:0002173) | 2.30264468 |
| 47 | Ragged-red muscle fibers (HP:0003200) | 2.30186293 |
| 48 | Systemic lupus erythematosus (HP:0002725) | 2.29578598 |
| 49 | Hypobetalipoproteinemia (HP:0003563) | 2.28721179 |
| 50 | Abnormality of complement system (HP:0005339) | 2.26581573 |
| 51 | Dysmetric saccades (HP:0000641) | 2.25744224 |
| 52 | Abnormality of purine metabolism (HP:0004352) | 2.25289946 |
| 53 | Natal tooth (HP:0000695) | 2.25203868 |
| 54 | Beaking of vertebral bodies (HP:0004568) | 2.19104932 |
| 55 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.19074809 |
| 56 | Interstitial pulmonary disease (HP:0006530) | 2.15502636 |
| 57 | Joint hemorrhage (HP:0005261) | 2.15457369 |
| 58 | Fragile skin (HP:0001030) | 2.14758459 |
| 59 | Nasal polyposis (HP:0100582) | 2.14558907 |
| 60 | Cerebral aneurysm (HP:0004944) | 2.14436645 |
| 61 | Abnormality of the nasal mucosa (HP:0000433) | 2.14314234 |
| 62 | Achilles tendon contracture (HP:0001771) | 2.13758130 |
| 63 | Hyperlipoproteinemia (HP:0010980) | 2.13711686 |
| 64 | Long toe (HP:0010511) | 2.12899851 |
| 65 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.12471253 |
| 66 | Increased connective tissue (HP:0009025) | 2.11614908 |
| 67 | Microvesicular hepatic steatosis (HP:0001414) | 2.10337283 |
| 68 | Proximal placement of thumb (HP:0009623) | 2.09285458 |
| 69 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.07979744 |
| 70 | Abnormal cartilage morphology (HP:0002763) | 2.06882282 |
| 71 | Progressive external ophthalmoplegia (HP:0000590) | 2.05139616 |
| 72 | Abdominal distention (HP:0003270) | 2.02707885 |
| 73 | Abnormal tarsal ossification (HP:0008369) | 2.02501294 |
| 74 | Hyperammonemia (HP:0001987) | 2.02037505 |
| 75 | Protrusio acetabuli (HP:0003179) | 2.01292637 |
| 76 | Protuberant abdomen (HP:0001538) | 2.00208351 |
| 77 | Thoracic kyphosis (HP:0002942) | 1.99923195 |
| 78 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.99390099 |
| 79 | Hyperparathyroidism (HP:0000843) | 1.98861187 |
| 80 | Thin bony cortex (HP:0002753) | 1.98796703 |
| 81 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.98537925 |
| 82 | Menorrhagia (HP:0000132) | 1.97156533 |
| 83 | Distal lower limb muscle weakness (HP:0009053) | 1.96627698 |
| 84 | Advanced eruption of teeth (HP:0006288) | 1.95058916 |
| 85 | Spastic diplegia (HP:0001264) | 1.93732768 |
| 86 | Global brain atrophy (HP:0002283) | 1.93418627 |
| 87 | Disproportionate tall stature (HP:0001519) | 1.93165370 |
| 88 | Generalized aminoaciduria (HP:0002909) | 1.93105365 |
| 89 | Hand muscle atrophy (HP:0009130) | 1.92858538 |
| 90 | Aneurysm (HP:0002617) | 1.92518852 |
| 91 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.92054873 |
| 92 | Cervical subluxation (HP:0003308) | 1.91453271 |
| 93 | Blue sclerae (HP:0000592) | 1.90638084 |
| 94 | Skin nodule (HP:0200036) | 1.90112789 |
| 95 | Pancreatitis (HP:0001733) | 1.89893574 |
| 96 | Squamous cell carcinoma (HP:0002860) | 1.89801847 |
| 97 | Abnormality of the thoracic spine (HP:0100711) | 1.89623895 |
| 98 | Spinal cord lesions (HP:0100561) | 1.87889832 |
| 99 | Syringomyelia (HP:0003396) | 1.87889832 |
| 100 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.87686198 |
| 101 | Abnormal foot bone ossification (HP:0010675) | 1.87198431 |
| 102 | Chronic otitis media (HP:0000389) | 1.86478218 |
| 103 | Abnormality of the lumbar spine (HP:0100712) | 1.86125293 |
| 104 | Glomerulonephritis (HP:0000099) | 1.85962538 |
| 105 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.85875801 |
| 106 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.85875801 |
| 107 | Abnormal platelet function (HP:0011869) | 1.85008447 |
| 108 | Impaired platelet aggregation (HP:0003540) | 1.85008447 |
| 109 | Steatorrhea (HP:0002570) | 1.83914453 |
| 110 | Hypokinesia (HP:0002375) | 1.83741043 |
| 111 | Hyperglycinemia (HP:0002154) | 1.82949944 |
| 112 | Micronodular cirrhosis (HP:0001413) | 1.82877164 |
| 113 | Hypolipoproteinemia (HP:0010981) | 1.82426162 |
| 114 | Progressive muscle weakness (HP:0003323) | 1.81375939 |
| 115 | Aortic aneurysm (HP:0004942) | 1.80586948 |
| 116 | Spinal cord compression (HP:0002176) | 1.80358636 |
| 117 | Severe short stature (HP:0003510) | 1.80025809 |
| 118 | Wormian bones (HP:0002645) | 1.79716900 |
| 119 | Symptomatic seizures (HP:0011145) | 1.79056453 |
| 120 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.78985518 |
| 121 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.77755599 |
| 122 | Hyperglycemia (HP:0003074) | 1.76734390 |
| 123 | Abnormal ossification of hand bones (HP:0005921) | 1.76556124 |
| 124 | Multiple enchondromatosis (HP:0005701) | 1.76189514 |
| 125 | Atrophic scars (HP:0001075) | 1.75935926 |
| 126 | Rough bone trabeculation (HP:0100670) | 1.75737882 |
| 127 | Nuclear cataract (HP:0100018) | 1.74908095 |
| 128 | Hyperbilirubinemia (HP:0002904) | 1.74792369 |
| 129 | Retinal atrophy (HP:0001105) | 1.74709435 |
| 130 | Patellar dislocation (HP:0002999) | 1.73002145 |
| 131 | Conjunctival hamartoma (HP:0100780) | 1.72580879 |
| 132 | Death in childhood (HP:0003819) | 1.72494666 |
| 133 | Abnormality of the umbilical cord (HP:0010881) | 1.72157154 |
| 134 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.71902199 |
| 135 | Hepatocellular carcinoma (HP:0001402) | 1.71617881 |
| 136 | Thoracolumbar scoliosis (HP:0002944) | 1.71471180 |
| 137 | Type II lissencephaly (HP:0007260) | 1.71363877 |
| 138 | Broad distal phalanx of finger (HP:0009836) | 1.71266430 |
| 139 | Upper limb amyotrophy (HP:0009129) | 1.70706802 |
| 140 | Distal upper limb amyotrophy (HP:0007149) | 1.70706802 |
| 141 | Joint stiffness (HP:0001387) | 1.70519366 |
| 142 | Bone pain (HP:0002653) | 1.70505044 |
| 143 | Pili torti (HP:0003777) | 1.70154526 |
| 144 | Back pain (HP:0003418) | 1.69327183 |
| 145 | Eczematoid dermatitis (HP:0000976) | 1.69321556 |
| 146 | Peritonitis (HP:0002586) | 1.69197343 |
| 147 | Colitis (HP:0002583) | 1.68979341 |
| 148 | Sensorimotor neuropathy (HP:0007141) | 1.68588962 |
| 149 | Malnutrition (HP:0004395) | 1.67939510 |
| 150 | Gastrointestinal inflammation (HP:0004386) | 1.67608680 |
| 151 | Thrombocytosis (HP:0001894) | 1.67490403 |
| 152 | Overlapping toe (HP:0001845) | 1.65084221 |
| 153 | Abnormality of carpal bone ossification (HP:0006257) | 1.64756985 |
| 154 | Insomnia (HP:0100785) | 1.64503098 |
| 155 | Entropion (HP:0000621) | 1.63581611 |
| 156 | Termporal pattern (HP:0011008) | 1.63258782 |
| 157 | Insidious onset (HP:0003587) | 1.63258782 |
| 158 | Flared metaphyses (HP:0003015) | 1.62941518 |
| 159 | Ankle contracture (HP:0006466) | 1.62666848 |
| 160 | Ridged nail (HP:0001807) | 1.62553932 |
| 161 | Dislocated radial head (HP:0003083) | 1.62479111 |
| 162 | Deep philtrum (HP:0002002) | 1.60460765 |
| 163 | Abnormality of the tricuspid valve (HP:0001702) | 1.58359291 |
| 164 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.56004806 |
| 165 | Breast hypoplasia (HP:0003187) | 1.54957839 |
| 166 | Mitral regurgitation (HP:0001653) | 1.54753253 |
| 167 | Long eyelashes (HP:0000527) | 1.54182645 |
| 168 | Nonimmune hydrops fetalis (HP:0001790) | 1.52938677 |
| 169 | Neonatal death (HP:0003811) | 1.52768526 |
| 170 | Acanthosis nigricans (HP:0000956) | 1.51723887 |
| 171 | Nail dystrophy (HP:0008404) | 1.51596013 |
| 172 | Generalized amyotrophy (HP:0003700) | 1.51404519 |
| 173 | Subacute progressive viral hepatitis (HP:0006572) | 1.50561744 |
| 174 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.50445388 |
| 175 | Mitral stenosis (HP:0001718) | 1.50256203 |
| 176 | Bowing of the arm (HP:0006488) | 1.50177003 |
| 177 | Bowed forearm bones (HP:0003956) | 1.50177003 |
| 178 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.49313435 |
| 179 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.48472724 |
| 180 | Biconcave vertebral bodies (HP:0004586) | 1.47284048 |
| 181 | Abnormality of the calcaneus (HP:0008364) | 1.47213017 |
| 182 | Hemorrhage of the eye (HP:0011885) | 1.47161460 |
| 183 | Lower limb amyotrophy (HP:0007210) | 1.46244986 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 5.15701225 |
| 2 | TRIB3 | 4.97913399 |
| 3 | PKN2 | 3.88414088 |
| 4 | SMG1 | 3.14190460 |
| 5 | ICK | 3.12844370 |
| 6 | BCKDK | 3.12041287 |
| 7 | SCYL2 | 2.99170113 |
| 8 | PRPF4B | 2.88925527 |
| 9 | CDK12 | 2.81126731 |
| 10 | TAOK3 | 2.66718704 |
| 11 | PASK | 2.41539757 |
| 12 | INSRR | 2.40443788 |
| 13 | PTK6 | 2.10161484 |
| 14 | FRK | 2.05595308 |
| 15 | EEF2K | 2.03798745 |
| 16 | SIK1 | 1.99497237 |
| 17 | MAP3K10 | 1.94866342 |
| 18 | NME2 | 1.83063613 |
| 19 | LRRK2 | 1.75117491 |
| 20 | FLT3 | 1.66225296 |
| 21 | MET | 1.64060464 |
| 22 | RIPK1 | 1.63563524 |
| 23 | MAP3K2 | 1.62242759 |
| 24 | FGFR4 | 1.59203750 |
| 25 | ZAP70 | 1.56639111 |
| 26 | MAP4K1 | 1.55255251 |
| 27 | TBK1 | 1.54731216 |
| 28 | ARAF | 1.45514170 |
| 29 | PDGFRA | 1.45308826 |
| 30 | PBK | 1.44594624 |
| 31 | RPS6KB2 | 1.39748539 |
| 32 | MAP3K3 | 1.39027984 |
| 33 | IRAK3 | 1.37939997 |
| 34 | TYK2 | 1.34124052 |
| 35 | CAMKK1 | 1.33527135 |
| 36 | BUB1 | 1.28765418 |
| 37 | LATS2 | 1.26230185 |
| 38 | JAK3 | 1.26049400 |
| 39 | PDK2 | 1.24007607 |
| 40 | MAP3K13 | 1.17432488 |
| 41 | KSR2 | 1.16735058 |
| 42 | MAP2K2 | 1.16058818 |
| 43 | MAP2K3 | 1.15602675 |
| 44 | EIF2AK1 | 1.13486722 |
| 45 | MAP3K1 | 1.12897818 |
| 46 | TAOK2 | 1.11876843 |
| 47 | EIF2AK3 | 1.10574957 |
| 48 | RET | 1.05646228 |
| 49 | TESK1 | 1.05279155 |
| 50 | EPHB1 | 1.04320251 |
| 51 | CDK7 | 1.02953807 |
| 52 | JAK2 | 1.02860000 |
| 53 | TTN | 1.02334531 |
| 54 | GRK6 | 1.01880787 |
| 55 | TTK | 1.00802405 |
| 56 | JAK1 | 1.00683564 |
| 57 | RAF1 | 1.00353305 |
| 58 | TGFBR2 | 0.99396275 |
| 59 | PAK4 | 0.99222475 |
| 60 | TESK2 | 0.98566703 |
| 61 | CDC7 | 0.98102073 |
| 62 | MST1R | 0.96021459 |
| 63 | BTK | 0.92381692 |
| 64 | CDK4 | 0.89392783 |
| 65 | PRKD3 | 0.88298859 |
| 66 | BRAF | 0.88037684 |
| 67 | IRAK2 | 0.86565167 |
| 68 | TAOK1 | 0.86173442 |
| 69 | PTK2 | 0.83300680 |
| 70 | CDK8 | 0.82509979 |
| 71 | MAPKAPK3 | 0.78834314 |
| 72 | NEK9 | 0.76915921 |
| 73 | PAK2 | 0.76359336 |
| 74 | DYRK1B | 0.75073413 |
| 75 | BRSK1 | 0.74221500 |
| 76 | CHEK2 | 0.73330866 |
| 77 | AURKA | 0.70701264 |
| 78 | HIPK2 | 0.70625816 |
| 79 | PIK3CG | 0.69084048 |
| 80 | MAP3K11 | 0.68715544 |
| 81 | MAP3K9 | 0.66495561 |
| 82 | IKBKE | 0.66110711 |
| 83 | KDR | 0.66061848 |
| 84 | PRKCH | 0.65947132 |
| 85 | PDGFRB | 0.65885829 |
| 86 | AURKB | 0.64028336 |
| 87 | NEK1 | 0.63688271 |
| 88 | ABL2 | 0.63518460 |
| 89 | CHEK1 | 0.61704068 |
| 90 | CSK | 0.60834540 |
| 91 | MAP2K1 | 0.60500633 |
| 92 | IRAK4 | 0.58337459 |
| 93 | RIPK4 | 0.57355064 |
| 94 | MELK | 0.57133198 |
| 95 | TSSK6 | 0.56964783 |
| 96 | SRPK1 | 0.56760207 |
| 97 | SYK | 0.54304812 |
| 98 | NTRK1 | 0.54294407 |
| 99 | MAP3K14 | 0.54037953 |
| 100 | WNK4 | 0.53079088 |
| 101 | PDK1 | 0.52839833 |
| 102 | STK4 | 0.52282168 |
| 103 | RPS6KA4 | 0.51271548 |
| 104 | KIT | 0.51259652 |
| 105 | CDK9 | 0.51076142 |
| 106 | ITK | 0.49701697 |
| 107 | ILK | 0.49649535 |
| 108 | PDPK1 | 0.49182167 |
| 109 | PIM2 | 0.49063409 |
| 110 | FGFR3 | 0.47885087 |
| 111 | CAMKK2 | 0.45161865 |
| 112 | MAPK11 | 0.44961577 |
| 113 | MAP3K8 | 0.44632124 |
| 114 | TGFBR1 | 0.44513638 |
| 115 | MAP3K7 | 0.44279355 |
| 116 | HCK | 0.43736461 |
| 117 | STK24 | 0.43454468 |
| 118 | ALK | 0.41947497 |
| 119 | STK10 | 0.41312023 |
| 120 | CSF1R | 0.40954823 |
| 121 | RPS6KL1 | 0.40829303 |
| 122 | RPS6KC1 | 0.40829303 |
| 123 | PRKCI | 0.40643437 |
| 124 | WEE1 | 0.40077144 |
| 125 | AKT2 | 0.40071922 |
| 126 | BLK | 0.40038474 |
| 127 | PRKD2 | 0.39834251 |
| 128 | EPHA3 | 0.39160516 |
| 129 | MARK2 | 0.39069908 |
| 130 | EGFR | 0.38927575 |
| 131 | RPS6KA2 | 0.38759144 |
| 132 | CDC42BPA | 0.36789505 |
| 133 | MTOR | 0.36636795 |
| 134 | NEK2 | 0.36605443 |
| 135 | PRKG2 | 0.35175159 |
| 136 | NEK6 | 0.34971663 |
| 137 | ATR | 0.34618776 |
| 138 | BMX | 0.34453103 |
| 139 | NME1 | 0.33216953 |
| 140 | LCK | 0.32918741 |
| 141 | LMTK2 | 0.32812171 |
| 142 | GSK3A | 0.32759027 |
| 143 | CAMK1D | 0.32674524 |
| 144 | FES | 0.32567205 |
| 145 | CDK6 | 0.31644367 |
| 146 | PAK1 | 0.31591310 |
| 147 | LATS1 | 0.31360498 |
| 148 | RPS6KA1 | 0.31243481 |
| 149 | CDK2 | 0.29252787 |
| 150 | IRAK1 | 0.29065230 |
| 151 | LYN | 0.28777198 |
| 152 | TEC | 0.28383625 |
| 153 | SIK2 | 0.27566475 |
| 154 | DDR2 | 0.27488677 |
| 155 | FER | 0.27397520 |
| 156 | EPHA2 | 0.26390852 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.32896153 |
| 2 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 3.15547233 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 3.04422432 |
| 4 | Protein export_Homo sapiens_hsa03060 | 2.80625352 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.44050373 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.37922208 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.23389068 |
| 8 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.20967880 |
| 9 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.06303616 |
| 10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.99124848 |
| 11 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.95675298 |
| 12 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.90544375 |
| 13 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.89559890 |
| 14 | Cell cycle_Homo sapiens_hsa04110 | 1.85114933 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.78965740 |
| 16 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.78380503 |
| 17 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.78113440 |
| 18 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.77752561 |
| 19 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.75204315 |
| 20 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.71539598 |
| 21 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.70689783 |
| 22 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.69586834 |
| 23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.67941880 |
| 24 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.62250815 |
| 25 | Sulfur relay system_Homo sapiens_hsa04122 | 1.60147766 |
| 26 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.59879100 |
| 27 | Lysosome_Homo sapiens_hsa04142 | 1.58907439 |
| 28 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.57075273 |
| 29 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.53942426 |
| 30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.47966263 |
| 31 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.44301841 |
| 32 | Base excision repair_Homo sapiens_hsa03410 | 1.42463930 |
| 33 | Mismatch repair_Homo sapiens_hsa03430 | 1.39513921 |
| 34 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.36195446 |
| 35 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.35310603 |
| 36 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.32668720 |
| 37 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.31664869 |
| 38 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.28919759 |
| 39 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.28447869 |
| 40 | Endometrial cancer_Homo sapiens_hsa05213 | 1.25650689 |
| 41 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.24399789 |
| 42 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.23345647 |
| 43 | Other glycan degradation_Homo sapiens_hsa00511 | 1.22899592 |
| 44 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.21319157 |
| 45 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.17354182 |
| 46 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.16170530 |
| 47 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.15744515 |
| 48 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.15205232 |
| 49 | RNA transport_Homo sapiens_hsa03013 | 1.14147610 |
| 50 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.13542066 |
| 51 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.12983261 |
| 52 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.11518640 |
| 53 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.10864095 |
| 54 | Bile secretion_Homo sapiens_hsa04976 | 1.10824982 |
| 55 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.09898558 |
| 56 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.09763829 |
| 57 | Spliceosome_Homo sapiens_hsa03040 | 1.06405566 |
| 58 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.05323172 |
| 59 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.04775615 |
| 60 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.04620288 |
| 61 | Insulin resistance_Homo sapiens_hsa04931 | 1.02855126 |
| 62 | Lysine degradation_Homo sapiens_hsa00310 | 1.00645966 |
| 63 | Prostate cancer_Homo sapiens_hsa05215 | 1.00519770 |
| 64 | Apoptosis_Homo sapiens_hsa04210 | 0.99946009 |
| 65 | Glioma_Homo sapiens_hsa05214 | 0.97994244 |
| 66 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.97344709 |
| 67 | Histidine metabolism_Homo sapiens_hsa00340 | 0.94227667 |
| 68 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.94147565 |
| 69 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.93412941 |
| 70 | Hepatitis B_Homo sapiens_hsa05161 | 0.92605652 |
| 71 | Focal adhesion_Homo sapiens_hsa04510 | 0.90269182 |
| 72 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.90232602 |
| 73 | Carbon metabolism_Homo sapiens_hsa01200 | 0.89458188 |
| 74 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.89415843 |
| 75 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.88938411 |
| 76 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.88003307 |
| 77 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.87790562 |
| 78 | HTLV-I infection_Homo sapiens_hsa05166 | 0.87586843 |
| 79 | Peroxisome_Homo sapiens_hsa04146 | 0.87172497 |
| 80 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.86198265 |
| 81 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.85815343 |
| 82 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.85610852 |
| 83 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.85359256 |
| 84 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.85164744 |
| 85 | ABC transporters_Homo sapiens_hsa02010 | 0.83744835 |
| 86 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.82700877 |
| 87 | Galactose metabolism_Homo sapiens_hsa00052 | 0.82163473 |
| 88 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.79684258 |
| 89 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.78605529 |
| 90 | Adherens junction_Homo sapiens_hsa04520 | 0.78340310 |
| 91 | Prion diseases_Homo sapiens_hsa05020 | 0.77341652 |
| 92 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.77131121 |
| 93 | Legionellosis_Homo sapiens_hsa05134 | 0.76754473 |
| 94 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.76261873 |
| 95 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.75559640 |
| 96 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.74888897 |
| 97 | Hepatitis C_Homo sapiens_hsa05160 | 0.74875569 |
| 98 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.74013462 |
| 99 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.73343433 |
| 100 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.71801446 |
| 101 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.71697348 |
| 102 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.71322198 |
| 103 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.70351891 |
| 104 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.70145237 |
| 105 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.68830246 |
| 106 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.67229612 |
| 107 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.66582670 |
| 108 | Shigellosis_Homo sapiens_hsa05131 | 0.66550590 |
| 109 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.66305739 |
| 110 | Colorectal cancer_Homo sapiens_hsa05210 | 0.65678897 |
| 111 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.65268302 |
| 112 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.62579016 |
| 113 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.62030325 |
| 114 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.60906360 |
| 115 | Ribosome_Homo sapiens_hsa03010 | 0.60678867 |
| 116 | Leishmaniasis_Homo sapiens_hsa05140 | 0.58481360 |
| 117 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.57488242 |
| 118 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.56670286 |
| 119 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.56405630 |
| 120 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.56379882 |
| 121 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.55179174 |
| 122 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.54940129 |
| 123 | Bladder cancer_Homo sapiens_hsa05219 | 0.54701518 |
| 124 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.53891701 |
| 125 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.53234921 |
| 126 | Alcoholism_Homo sapiens_hsa05034 | 0.52006462 |
| 127 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.51989203 |
| 128 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.51675700 |
| 129 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.50683388 |
| 130 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.50631451 |
| 131 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.50190342 |
| 132 | Amoebiasis_Homo sapiens_hsa05146 | 0.50059389 |
| 133 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.49416392 |
| 134 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.47233090 |
| 135 | Influenza A_Homo sapiens_hsa05164 | 0.46508760 |
| 136 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.45285927 |
| 137 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.44942992 |
| 138 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.44568982 |
| 139 | Pertussis_Homo sapiens_hsa05133 | 0.44547742 |
| 140 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.44295673 |
| 141 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.44252376 |
| 142 | Pathways in cancer_Homo sapiens_hsa05200 | 0.43980896 |
| 143 | Melanoma_Homo sapiens_hsa05218 | 0.43560184 |
| 144 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.42522298 |
| 145 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.41326230 |
| 146 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.41108655 |
| 147 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.40075126 |
| 148 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.40032787 |
| 149 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.39562727 |
| 150 | Tuberculosis_Homo sapiens_hsa05152 | 0.39011543 |
| 151 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.38028067 |
| 152 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.36617742 |
| 153 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.36499711 |
| 154 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.36351949 |
| 155 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.35479515 |
| 156 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.35294752 |
| 157 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.34853142 |
| 158 | Thyroid cancer_Homo sapiens_hsa05216 | 0.34722298 |
| 159 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.34302439 |

